Baccelli, I., Stenzinger, A., Vogel, V., Pfitzner, B.M., Klein, C., Wallwiener, M., Scharpff, M., Saini, M., Holland-Letz, T., Sinn, H.P., Schneeweiss, A., Denkert, C., Weichert, W., & Trumpp, A. (2014). Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients. Oncotarget, 5(18), 8147-8160. doi: 10.18632/oncotarget.2385

Links and further information

Pubmed | Read at Publisher